Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kathleen Galatro"'
Autor:
Farooq A. Chaudhry, Peter Dourdoufis, Ami E. Iskandrian, Aman Amanullah, S. Brozena, Kathleen Galatro, Jaekyeong Heo, Jagat Narula
Publikováno v:
The American Journal of Cardiology. 84:626-631
Both dobutamine stress echocardiography (DSE) and myocardial perfusion scintigraphy are used to assess myocardial viability. Few studies have compared the data on myocardial viability and ischemia by low and peak dose DSE and myocardial perfusion ima
Publikováno v:
Echocardiography (Mount Kisco, N.Y.). 17(5)
The extent and degree of myocardial viability are important parameters in the risk stratification of patients with significant left ventricular dysfunction secondary to coronary artery disease. Although several imaging modalities can identify viable
Autor:
Kathleen Galatro, Farooq A. Chaudhry
Publikováno v:
Echocardiography (Mount Kisco, N.Y.). 17(1)
The extent and degree of myocardial viability is an important parameter in the risk stratification of patients with significant left ventricular dysfuncion due to coronary artery disease (CAD). Although several imaging modalities can identify viable
Autor:
Farooq A. Chaudhry, Kathleen Galatro
Publikováno v:
Myocardial Viability ISBN: 9789401057936
Left ventricular function is one of the most important determinates of long term prognosis in patients with coronary artery disease [1]. In recent years it has become apparent that left ventricular dysfunction in patients with coronary artery disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5072002f878ea7e0cb353a99754a12c
https://doi.org/10.1007/978-94-011-4080-5_9
https://doi.org/10.1007/978-94-011-4080-5_9
Publikováno v:
Echocardiography; Jul2000, Vol. 17 Issue 5, p495-506, 12p
Autor:
GALATRO, KATHLEEN, CHAUDHRY, FAROOQ A.
Publikováno v:
Echocardiography; Jan2000, Vol. 17 Issue 1, p61-67, 7p
Autor:
A.E. Iskandrian, Ernst E. van der Wall
AMI E. ISKANDRIAN & ERNST E. VAN DER WALL The first edition of this book was published in 1994. Since then important advances have occurred in the field of myocardial viability. This, coupled with increasing interest by the scientific community in th